Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Keating

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Cancer|July 29, 2009
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemiaNitin Jain, William Wierda, Alessandra Ferrajoli, et al.
BMC Health Services Research|June 21, 2017
Factors influencing professional life satisfaction among neurologistsStephanie M Teixeira-Poit, Michael T Halpern, Heather L Kane, et al.
The Journal of Arthroplasty|April 3, 2007
A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strengthE Michael Keating, John J Callaghan, Amar S Ranawat, et al.
Clinical Orthopaedics and Related Research|March 8, 2008
Hybrid total knee arthroplasty: 13-year survivorship of AGC total knee systems with average 7 years followupPhilip M Faris, E Michael Keating, Alex Farris, et al.
The Journal of Bone and Joint Surgery. American Volume|March 15, 2003
The AGC all-polyethylene tibial component: a ten-year clinical evaluationPhilip M Faris, Merrill A Ritter, E Michael Keating, et al.
Clinical Orthopaedics and Related Research|August 21, 2008
Predicting patellar failure after total knee arthroplastyJohn B Meding, Mark D Fish, Michael E Berend, et al.
The Journal of Arthroplasty|January 25, 2014
Use of screws and cement in primary TKA with up to 20 years follow-upMichael E Berend, Merrill A Ritter, E Michael Keating, et al.
Clinical Orthopaedics and Related Research|December 4, 2003
Genu recurvatum in total knee replacementJohn B Meding, E Michael Keating, Merrill A Ritter, et al.
The Journal of Bone and Joint Surgery. American Volume|January 9, 2004
Minimum ten-year follow-up of a straight-stemmed, plasma-sprayed, titanium-alloy, uncemented femoral component in primary total hip arthroplastyJohn B Meding, E Michael Keating, Merrill A Ritter, et al.
Clinical Orthopaedics and Related Research|November 10, 2004
Long-term followup of posterior-cruciate-retaining TKR in patients with rheumatoid arthritisJohn B Meding, E Michael Keating, Merrill A Ritter, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Cancer|July 29, 2009
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemiaNitin Jain, William Wierda, Alessandra Ferrajoli, et al.
BMC Health Services Research|June 21, 2017
Factors influencing professional life satisfaction among neurologistsStephanie M Teixeira-Poit, Michael T Halpern, Heather L Kane, et al.
The Journal of Arthroplasty|April 3, 2007
A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strengthE Michael Keating, John J Callaghan, Amar S Ranawat, et al.
Clinical Orthopaedics and Related Research|March 8, 2008
Hybrid total knee arthroplasty: 13-year survivorship of AGC total knee systems with average 7 years followupPhilip M Faris, E Michael Keating, Alex Farris, et al.
The Journal of Bone and Joint Surgery. American Volume|March 15, 2003
The AGC all-polyethylene tibial component: a ten-year clinical evaluationPhilip M Faris, Merrill A Ritter, E Michael Keating, et al.
Clinical Orthopaedics and Related Research|August 21, 2008
Predicting patellar failure after total knee arthroplastyJohn B Meding, Mark D Fish, Michael E Berend, et al.
The Journal of Arthroplasty|January 25, 2014
Use of screws and cement in primary TKA with up to 20 years follow-upMichael E Berend, Merrill A Ritter, E Michael Keating, et al.
Clinical Orthopaedics and Related Research|December 4, 2003
Genu recurvatum in total knee replacementJohn B Meding, E Michael Keating, Merrill A Ritter, et al.
The Journal of Bone and Joint Surgery. American Volume|January 9, 2004
Minimum ten-year follow-up of a straight-stemmed, plasma-sprayed, titanium-alloy, uncemented femoral component in primary total hip arthroplastyJohn B Meding, E Michael Keating, Merrill A Ritter, et al.
Clinical Orthopaedics and Related Research|November 10, 2004
Long-term followup of posterior-cruciate-retaining TKR in patients with rheumatoid arthritisJohn B Meding, E Michael Keating, Merrill A Ritter, et al.
Pageof 19